Additionally, after a 26-week experiment, the high-dose THE treatment significantly deceased liver weight, abdominal adipose weight, and attenuated the elevation of all observed plasma parameters, including glucose (by 31.92%), insulin (by 33.40%), T-CHO (by 38.80%), TG (by 26.13%), and LDL-C (by 42.26%), compared to continuous HF group mice (Figure 1B–H). This evidence concerns the gene INS and hydrops fetalis.